Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29518815 | 0.77 | BBOX1 (0.50) | — | |
| SCHEMBL6536405 | 0.74 | BBOX1 (0.48) | — | |
| SCHEMBL646481 | 0.72 | — | — | |
| SCHEMBL6536406 | 0.72 | BBOX1 (0.46) | — | |
| SCHEMBL31268422 | 0.72 | BBOX1 (0.52) | — | |
| SCHEMBL214687 | 0.71 | KDM4E (0.62) | — | |
| SCHEMBL10041202 | 0.69 | — | — | |
| SCHEMBL5889202 | 0.69 | BBOX1 (0.48) | — | |
| SCHEMBL28995844 | 0.69 | BBOX1 (0.43) | — | |
| SCHEMBL2400456 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069556-A1 | Use of N-Chlorotaurine for Treatment and Prevention of Viral Infections | NAGL MARKUS (AT) | 2026-03-12 | — | — | US | disclosed |
| US-20250073190-A1 | Compositions and Use of N-Chlorotaurine for Treatment and Prevention of Respiratory Infections | NAGL MARKUS (AT) | 2025-03-06 | — | — | US | disclosed |
| US-12171732-B2 | Compositions and use of N-chlorotaurine for treatment and prevention of respiratory infections | NAGL MARKUS (AT) | 2024-12-24 | — | — | US | disclosed |
| US-20220273594-A1 | Compositions and Use of N-Chlorotaurine for Treatment and Prevention of Respiratory Infections | NAGL MARKUS (AT) | 2022-09-01 | — | — | US | disclosed |
| EP-2265267-B1 | COMPOSITIONS COMPRISING N-HALOGENATED OR N, N-DIHALOGENATED AMINE FOR TREATMENT AND PROPHYLAXIS OF BRONCHOPULMONARY INFECTIONS | GOTTARDI WALDEMAR (AT) | 2016-09-21 | — | — | EP | disclosed |
| US-20110151025-A1 | Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections | NOVABAY PHARMACEUTICALS, INC. | 2011-06-23 | — | — | US | disclosed |
| US-20110091570-A1 | Compositions and Devices for Antisepsis and Anticoagulation | GOTTARDI WALDEMAR | 2011-04-21 | — | — | US | disclosed |
| EP-2271331-A1 | COMPOSITIONS AND DEVICES FOR ANTISEPSIS AND ANTICOAGULATION | Gottardi, Waldemar (AT) | 2011-01-12 | — | — | EP | disclosed |
| EP-2265267-A1 | COMPOSITIONS COMPRISING N-HALOGENATED OR N, N-DIHALOGENATED AMINE FOR TREATMENT AND PROPHYLAXIS OF BRONCHOPULMONARY INFECTIONS | NovaBay Pharmaceuticals, Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| WO-2009127924-A1 | COMPOSITIONS AND DEVICES FOR ANTISEPSIS AND ANTICOAGULATION | GOTTARDI WALDEMAR (AT) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009126912-A1 | COMPOSITIONS COMPRISING N-HALOGENATED OR N, N-DIHALOGENATED AMINE FOR TREATMENT AND PROPHYLAXIS OF BRONCHOPULMONARY INFECTIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2009-10-15 | — | — | WO | disclosed |
| US-20090029956-A1 | Substance mixture | PREGENZER BRUNO | 2009-01-29 | — | — | US | disclosed |